Events & public hearings
We track policy windows and hearings through the calendar and briefing archive. Use this page as a stable entry point for event-related queries.
Start here:
Recent briefing items
- Neuroimaging Predictors of Ketamine Response in Treatment
- DEA Schedules MDMB-4en-PINACA as Schedule I Substance
- Psyence's Phase IIb Trial for NPX-5 in Cancer Patients
- DOJ Reschedules Marijuana: Implications for Psychedelics
- Trump Orders FDA to Expedite Psychedelic Drug Reviews
- Psilocybin and Alternatives for Treatment-Resistant Depression